PC
STLN

Periscope Capital’s Starling Oncology STLN Stock Holding History

Periscope Capital’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-69,604
Closed -$692K – 981
2021
Q3 		$692K Sell
69,604
-5,196
-7% -$51.6K 0.02% 577
2021
Q2 		$744K Sell
74,800
-25,200
-25% -$254K 0.02% 526
2021
Q1 		$996K Hold
100,000
– – 0.04% 412
2020
Q4 		$1.08M Buy
+100,000
New +$1.03M 0.06% 280

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Periscope Capital's STLN Position: Q4 2021 in Review

Periscope Capital sold out of Starling Oncology (STLN) in Q4 2021, closing a stake of 69,604 shares — an estimated $692K sold.

Periscope Capital first reported a position in STLN in Q4 2020 and held it in 4 quarters. The position peaked at $1.08M in Q4 2020. 21 funds tracked by Wall St. Rank hold STLN as of Q4 2021.

  • Periscope Capital reported no remaining Starling Oncology position as of Q4 2021 after selling out during the quarter.
  • Periscope Capital sold 69,604 Starling Oncology shares in Q4 2021, an estimated $692K.
  • Periscope Capital first reported a position in Starling Oncology in Q4 2020 and held it in 4 quarters.
  • Periscope Capital's Starling Oncology position peaked at $1.08M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Starling Oncology as of Q4 2021.

Based on Periscope Capital's 13F filing for Q4 2021, filed 14 Feb 2022.